Abstract-Hyperspectral imaging is an emerging technology for biomedical applications. In this study, an advanced image processing and classification method is proposed to analyze hyperspectral image data for prostate cancer detection. Least squares support vector machines (LS-SVMs) were developed and evaluated for classifying hyperspectral data in order to enhance the detection of cancer tissue. The method was used to detect prostate cancer in tumor-bearing mice. Spatially resolved images were created to highlight the differences of the reflectance properties of cancer versus those of normal tissue. Preliminary results in mice show that the hyperspectral imaging and classification method was able to reliably detect prostate tumors in the animal model. The hyperspectral imaging technique may provide a new tool for optical diagnosis of cancer.
INTRODUCTION
Hyperspectral imaging (HSI) is a spin-off from remote sensing technology developed by NASA for space exploration and earth observation [1] . Hyperspectral imaging can extend human vision to infrared and near-infrared wavelength regions. In fact, the imaging system produces several narrow band images at different wavelengths. Compared to conventional color cameras and other filter-based imaging systems, this system produces full neighboring spectral data with spectral and spatial information [2] . In medical applications, hyperspectral image data provide a powerful tool for noninvasive tissue analysis. Hyperspectral imaging has been used to provide quantitative data regarding tissue oxygen saturation in patients with peripheral vascular disease [3] , to detect ischemic regions of the intestine during surgery [4] , to predict and follow healing in foot ulcers of diabetic patients [5] , and to diagnose hemorrhagic shock [6] .
Hyperspectral imaging has been used to discriminate between cancerous and normal tissue [7] . However, this method is limited to the visible wavelength range and requires the injection of fluorescent material. Hyperspectral imaging has also been evaluated for use in the cytologic diagnosis of cancer cells [8] . It has been reported that hyperspectral imaging is also used to detect gastric tumors in human subjects [9] . The spectral signatures of the gastric cancer and non-cancerous stomach tissue were created in infrared wavelengths. An HSI system with the spectral range of 500-600 nm has demonstrated its surgical application in breast cancer animal models [10] . The spectral information contained in hyperspectral image data allows characterization, identification, and classification of different types of tissue.
Various image processing methods have been developed in an attempt to resolve the hyperspectral data classification problem. The support vector machine (SVM) is one of the successful approaches to multispectral data classification [11] [12] [13] [14] . The properties of SVMs make them well-suited to tackle this classification problem as they can: 1) efficiently manage large input spaces; 2) deal with noisy samples in a robust way; and 3) produce sparse solutions, i.e., the decision boundary is expressed as a function of a subset of training samples.
In this research, we performed in vivo hyperspectral imaging experiments and proposed an SVM method for hyperspectral image classification of prostate tumor tissue. We identify spectral signatures of both normal and cancerous tissue in animals. The details of the experiments and methods are described in the following sections.
II. MATERIALS AND METHODS

A. Hyperspectral Imaging System
In this study, a CRi camera system (Caliper, Hopkinton, MA) was used to acquire hyperspectral image data from animals. The system is a light-tight apparatus that uses a Cermax-type 300 Watt Xenon light source. This provides 5600°K that spans the electromagnetic spectrum from 500-950nm. The CCD is a 16-bit, high-resolution, scientific-grade imaging sensor. Four, fiber-optic, adjustable illuminator arms yield an even light distribution to the subject. The light radiates from the excitation source and then illuminates the sample. Reflect lights pass through the camera lens to the solid-state liquid crystal tuning element and finally to the CCD. The excitation and emission filter sliders hold two, 50-mm diameter, long pass filters. The long pass filters remove the band light especially from the excitation source. These filters are color coded to indicate the wavelength they represent. The field of view (length × width) is from 3.4×2.5 cm to 10.2 ×7.6 cm with variable zoom. The resolution is from 25 to 75 μm based on the zoom lens position. The fluence rate, i.e., the flow of photons over a set angle, is from 4 to 20 mW/cm 2 based on the light position. The scan time is from 5 sec to 1 min.
B. Animal Tumor Model
A human prostate cancer xenograft model CWR22 [15, 16] was used in this study. The frozen CWR22 cancer cells were thawed in 37 o C water, washed with tissue culture medium (RPMI 1640, Hyclone Laboratories, Inc., Logan, UT) with 20% calf serum (Hyclone Laboratories, Inc., Logan, UT), and were then filtered through a single layer of Nitex with 100 μm porosity (Tetko, Inc., Briarcliff Manor, NY). The cells were suspended in Matrigel (BD Biosciences, Bedford, MA) with a volume at least equal to that of the cell volume. The suspension was draw into 1.0-cc syringes with 19- [17] . A 12.5-mg sustained-release testosterone pellet (Innovative Research of America, Sarasota, FL) was implanted in each nude mouse one week before cell injection. Each animal was subcutaneously given an injection of cells suspension on the other side of the implanted testosterone. The animal experiments were approved by our Institutional Animal Care and Use Committee (IACUC) and conformed to the guidelines of the National Institutes of Health for the care and use of laboratory animals.
In this study, the hyperspectral imaging experiment was performed on 11 male nude mice. Nine mice had human prostate tumors growing on the flank. During image acquisition, each mouse was anesthetized by i.p. injection of a ketamine and xylazine mixture at a dose of ketamine at 95 mg/kg and xylazine at 5 mg/kg body weight.
C. Support Vector Machine (SVM) for Image Classification
Least squares SVM (LS-SVM) is proposed to classify the hyperspectral data. LS-SVM has previously been applied to other applications [18] . This LS-SVM method allows us to interpret and design learning algorithms geometrically in the kernel space that is nonlinearly related to the input space, thus combining statistics and geometry in an effective way. In LSSVMs, the algorithm attempts to identify a ridge regression for classification using binary targets. Therefore, LS-SVM overcomes some of the disadvantages of classical SVM that attempts to identify a large margin for classification. In LSSVMs, equality constraints are considered for the classification problem with a formulation in the least squares sense. As a result the solution follows directly from solving a set of linear equations, instead of quadratic programming.
We first segment the tumor on one group of hyperspectral images for LS-SVM training. For a new group of hyperspectral images, the trained LS-SVM is used to perform the automatic classification of tumors on the new hyperspectral images. We have input vectors of 251 elements in 2-nm spectral resolution images. The output of the trained LS-SVM is the classification result of normal and cancer tissue on the image.
D. Classification Evaluation
The performance of the automatic classification was evaluated with respect to the gold-standard maps created manually by a medical doctor. Sensitivity and specificity were used as statistical measures of the performance of the binary classification method [19] [20] [21] . Sensitivity measures the proportion of actual positives which are correctly identified as positive, i.e. the percentage of tumor pixels which are correctly identified as tumor tissue. When a pixel was not detected as a tumor pixel, the detection was considered as a false negative if the pixel was indeed a tumor pixel in the manually created map. When a pixel was detected as a tumor tissue, the detection was a false positive if the pixel was not tumor tissue. Specificity measures the proportion of negatives which are correctly identified, i.e., the percentage of healthy tissue correctly identified as not having cancer.
III. RESULTS Fig. 1 shows the hyperspectral images of a tumor-bearing mouse. The hyperspectral image cube consists of twodimensional images at each narrow band wavelength and onedimensional spectra at each pixel. As shown on the graph (Fig.1B) , the spectra of the normal and tumor tissue are different. The spectral information was used by the SVM-based classification to differentiate normal and cancer tissue on the hyperspectral images. For the 11 mice, the sensitivity and specificity were 92.8±2.0% and 96.9±1.3%, respectively.
IV. CONCLUSION
We developed a hyperspectral image classification method for prostate cancer detection in an animal model. A least-squares support vector machine classifier was used to classify cancer tissue in animals. Our preliminary study has demonstrated the feasibility of using hyperspectral imaging and quantitative analysis methods for prostate cancer detection. Hyperspectral imaging offers a potential, noninvasive tool for surgeons to inspect and assess a large area of tissue without taking tissue sample for pathology examination. This method allows continuous evaluation of suspicious cancer tissue without interrupting surgery and could, therefore, be used as a virtual biopsy tool. 
